Jane Street Group, LLC Curis Inc Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$2.31 - $5.13 $61,908 - $137,484	-26,800 Reduced 40.36%	39,600 $94,000
Q4 2021 Feb 15, 2022	SELL	$4.45 - $8.09 $262,995 - $478,119	-59,100 Reduced 47.09%	66,400 $316,000
Q3 2021 Nov 16, 2021	SELL	$6.94 - $8.85 $170,724 - $217,710	-24,600 Reduced 16.39%	125,500 $983,000
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $84,185 - $183,851	11,300 Added 8.14%	150,100 $1.21 Million
Q1 2021 May 18, 2021	BUY	$8.78 - $12.8 $474,997 - $692,480	54,100 Added 63.87%	138,800 $1.57 Million
Q4 2020 Feb 17, 2021	BUY	$1.08 - $8.2 $91,476 - $694,539	84,700 New	84,700 $694,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.